New Ramipril alert as blood pressure medication 'has wrong dosage'
New Ramipril alert as blood pressure medication 'has wrong dosage'The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a safety alert Share Article Share Article Facebook X LinkedIn Reddit Bluesky Email Copy Link Link copied Bookmark Add us as preferred source Comments By Steven Smith, Content Editor 09:31, Fri, May 29, 2026 Updated: 09:36, Fri, May 29, 2026 The incorrect blister strip (Image: MHRA)Patients taking a common blood pressure medication have been warned of a potential issue that may require them to take immediate action. window.scriptsToLoad.push({url:'https://live.primis.tech/live/liveView.php?s=118222&vp_content=plembed3a6btjknzwqh&cbuster=%%CACHEBUSTER%%&playerApiId=v118222',triggeredBy:'tcfLoaded',delay:1500,containerId:'ovp-primis',title:"Primis player",beforeLoad:()=>{window.top.addEventListener('primisPlayerInit',e=>{try{if(e.detail&&e.detail.playerApiId==="v118222"){if(window.document.getElementsByClassName('jwplayer')[0]){e.detail.float('disable')}}}catch(e){}})},}) In an alert issued on Thursday, the Medicines and Healthcare products Regulatory Agency (MHRA) announced that Crescent Pharma Limited is recalling one batch of Ramipril 2.5mg capsules as a precautionary measure following a packaging error, which may mean certain cartons contain blister strips of a higher dose, specifically Ramipril 10mg. Article continues below ADVERTISEMENT Get health news, advice and symptoms to watch out for and more Subscribe Invalid emailWe use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. Read our Privacy PolicyThe recall was triggered by a complaint in which a healthcare professional discovered two blister strips of Ramipril 10mg capsules inside a sealed carton of Crescent Pharma Limited Ramipril 2.5mg capsules. The MHRA confirmed that both product batches were manufacture...المصدر: ديلي إكسبرس | Source: ديلي إكسبرس
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة ديلي إكسبرس. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by ديلي إكسبرس. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.





